Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC

Simple item page
dc.contributor.authorAntonia, S.
dc.contributor.authorVillegas, A.
dc.contributor.authorDaniel, D.
dc.contributor.authorVicente, D.
dc.contributor.authorMurakami, S.
dc.contributor.authorHui, R.
dc.contributor.authorKurata, T.
dc.contributor.authorChiappori, A.
dc.contributor.authorLee, K. H.
dc.contributor.authorDe Wit, M.
dc.contributor.authorCho, B. C.
dc.contributor.authorBourhaba, M.
dc.contributor.authorQuantin, X.
dc.contributor.authorTokito, T.
dc.contributor.authorMekhail, T.
dc.contributor.authorPlanchard, D.
dc.contributor.authorKim, Y.
dc.contributor.authorKarapetis, C.
dc.contributor.authorHiret, S.
dc.contributor.authorOstoros, G.
dc.contributor.authorKubota, K.
dc.contributor.authorGray, J.
dc.contributor.authorPaz-Ares, L.
dc.contributor.authorCarpeno, J. De Castro
dc.contributor.authorFaivre-Finn, C.
dc.contributor.authorReck, M.
dc.contributor.authorVansteenkiste, J.
dc.contributor.authorSpigel, D.
dc.contributor.authorWadsworth, C.
dc.contributor.authorTaboada, M.
dc.contributor.authorDennis, P.
dc.contributor.authorOzguroglu, M.
dc.contributor.authoraffiliation[Antonia, S.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
dc.contributor.authoraffiliation[Chiappori, A.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
dc.contributor.authoraffiliation[Villegas, A.] Canc Specialists North Florida, Jacksonville, FL USA
dc.contributor.authoraffiliation[Daniel, D.] Tennessee Oncol, Nashville, TN USA
dc.contributor.authoraffiliation[Vicente, D.] Hosp Univ Virgen Macarena, Seville, Spain
dc.contributor.authoraffiliation[Murakami, S.] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
dc.contributor.authoraffiliation[Hui, R.] Westmead Hosp, Westmead, NSW, Australia
dc.contributor.authoraffiliation[Hui, R.] Univ Sydney, Westmead, NSW, Australia
dc.contributor.authoraffiliation[Kurata, T.] Kansai Med Univ Hosp, Osaka, Japan
dc.contributor.authoraffiliation[Lee, K. H.] Chungbuk Natl Univ Hosp, Cheongju, South Korea
dc.contributor.authoraffiliation[De Wit, M.] Vivantes Klinikum Neukoelln, Berlin, Germany
dc.contributor.authoraffiliation[Cho, B. C.] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
dc.contributor.authoraffiliation[Bourhaba, M.] CHU Liege, Liege, Belgium
dc.contributor.authoraffiliation[Quantin, X.] CHU Montpellier, Montpellier, France
dc.contributor.authoraffiliation[Quantin, X.] Icm Val DAurelle, Montpellier, France
dc.contributor.authoraffiliation[Tokito, T.] Kurume Univ Hosp, Kurume, Fukuoka, Japan
dc.contributor.authoraffiliation[Mekhail, T.] Florida Hosp, Canc Inst, Orlando, FL USA
dc.contributor.authoraffiliation[Planchard, D.] Gustave Roussy, Villejuif, France
dc.contributor.authoraffiliation[Kim, Y.] Chonnam Natl Univ, Hwasun Hosp, Jeonnam, South Korea
dc.contributor.authoraffiliation[Karapetis, C.] Flinders Univ S Australia, Bedford Pk, SA, Australia
dc.contributor.authoraffiliation[Karapetis, C.] Flinders Med Ctr, Bedford Pk, SA, Australia
dc.contributor.authoraffiliation[Hiret, S.] Ico Site Rene Gauducheau, St Herblain, France
dc.contributor.authoraffiliation[Ostoros, G.] Natl Koranyi Inst Pulmonl, Budapest, Hungary
dc.contributor.authoraffiliation[Kubota, K.] Nippon Med Coll Hosp, Tokyo, Japan
dc.contributor.authoraffiliation[Gray, J.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
dc.contributor.authoraffiliation[Carpeno, J. De Castro] Hosp Univ La Paz, Madrid, Spain
dc.contributor.authoraffiliation[Faivre-Finn, C.] Univ Manchester, Manchester, Lancs, England
dc.contributor.authoraffiliation[Faivre-Finn, C.] Christie NHS Fdn Trust, Manchester, Lancs, England
dc.contributor.authoraffiliation[Reck, M.] German Ctr Lung Res, ARCH, Lung Clin, Grosshansdorf, Germany
dc.contributor.authoraffiliation[Vansteenkiste, J.] Univ Hosp KU Leuven, Leuven, Belgium
dc.contributor.authoraffiliation[Spigel, D.] Sarah Cannon Res Inst, Nasville, TN USA
dc.contributor.authoraffiliation[Wadsworth, C.] Astrazeneca, Alderley Pk, England
dc.contributor.authoraffiliation[Taboada, M.] Astrazeneca, Gaithersburg, TN USA
dc.contributor.authoraffiliation[Dennis, P.] Astrazeneca, Gaithersburg, MD USA
dc.contributor.authoraffiliation[Ozguroglu, M.] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Istanbul, Turkey
dc.date.accessioned2025-01-07T16:00:55Z
dc.date.available2025-01-07T16:00:55Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jtho.2018.08.010
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418309687/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27560
dc.identifier.wosID454014500002
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS184-S184
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectNSCLC
dc.subjectdurvalumab
dc.subjectPACIFIC
dc.titleOverall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía